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Identifying signaling pathways that regulate hematopoietic stem and progenitor cell (HSPC) formation in the
embryo will guide efforts to produce and expand HSPCs ex vivo. Here we show that sterile tonic inflammatory
signaling regulates embryonic HSPC formation. Expression profiling of progenitors with lymphoid potential and
hematopoietic stem cells (HSCs) from aorta/gonad/mesonephros (AGM) regions of midgestation mouse embryos
revealed a robust innate immune/inflammatory signature. Mouse embryos lacking interferon g (IFN-g) or IFN-a
signaling and zebrafish morphants lacking IFN-g and IFN-u activity had significantly fewer AGM HSPCs.
Conversely, knockdown of IFN regulatory factor 2 (IRF2), a negative regulator of IFN signaling, increased
expression of IFN target genes and HSPC production in zebrafish. Chromatin immunoprecipitation (ChIP)
combined with sequencing (ChIP-seq) and expression analyses demonstrated that IRF2-occupied genes identified
in human fetal liver CD34+ HSPCs are actively transcribed in human and mouse HSPCs. Furthermore, we
demonstrate that the primitive myeloid population contributes to the local inflammatory response to impact the
scale of HSPC production in the AGM region. Thus, sterile inflammatory signaling is an evolutionarily conserved
pathway regulating the production of HSPCs during embryonic development.
[Keywords: interferon; hematopoiesis; lymphoid progenitor; hematopoietic stem cell; mouse; zebrafish]
Supplemental material is available for this article.
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Hematopoiesis in the embryo begins with the emergence
of committed progenitors followed by hematopoietic
stem cells (HSCs). Primitive erythrocytes differenti-
ate in the yolk sac (YS) of mice from erythrocyte and
erythrocyte/megakaryocyte progenitors that emerge at
embryonic day 7.0 (E7.0) (Palis et al. 1999; Tober et al.
2007). Macrophage progenitors appear in the YS at E8.0,
and macrophages subsequently migrate throughout the
embryo (Palis et al. 1999; Bertrand et al. 2005). Definitive
erythrocytes andmyeloid lineage cells differentiate in the
YS starting at E8.25 from a committed erythro–myeloid
progenitor (EMP) (Bertrand et al. 2007; Frame et al. 2013).
Cells with lymphoid potential (B and T) can be found in
the YS and para-aortic splanchopleura at E8.5–E9.5 (Liu
and Auerbach 1991; Godin et al. 1995; Yokota et al. 2006;
Yoshimoto et al. 2012). HSCs first appear at E10.5–E11.5
in the aorta/gonad/mesonephros (AGM) region and um-
bilical and vitelline arteries (M€uller et al. 1994; de Bruijn
et al. 2000). Progenitors and HSCs differentiate directly
 2014 Li et al. This article is distributed exclusively by Cold Spring
Harbor Laboratory Press for the first six months after the full-issue
publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).
After six months, it is available under a Creative Commons License
(Attribution-NonCommercial 4.0 International), as described at http://
creativecommons.org/licenses/by-nc/4.0/.
9Present address: Children’s Research Institute, University of Texas
Southwestern Medical School, Dallas, Texas 75235, USA.
10These authors contributed equally to this work.
Corresponding authors: nancyas@exchange.upenn.edu, tnorth@bidmc.
harvard.edu
Article published online ahead of print. Article and publication date are
online at http://www.genesdev.org/cgi/doi/10.1101/gad.253302.114.
GENES & DEVELOPMENT 28:2597–2612 Published by Cold Spring Harbor Laboratory Press; ISSN 0890-9369/14; www.genesdev.org 2597
from hemogenic endothelium and briefly accumulate in
clusters in the aortic lumen before release into the
circulation to colonize the fetal liver (FL) (Swiers et al.
2013). How the embryo designates production of com-
mitted progenitors with limited potential versus HSCs
from hemogenic endothelium is not known.
Although lymphoid progenitors are detectable by E8.5–
E9.5 in mouse embryos and by 4 d post-fertilization (dpf)
in the thymus of zebrafish embryos, a functional adaptive
immune system is not present in mice until after birth
and is not present in zebrafish until 3 wk of age (Lam
et al. 2004; Page et al. 2013). However, as early as 1 dpf,
zebrafish embryos have a functional innate immune
system that can respond to bacterial and viral pathogens
in their environment (Davis et al. 2002). The cellular
effectors of innate immunity in the zebrafish embryo are
primitive macrophages and granulocytes, and molecular
components include pattern recognition receptor Toll-like
receptors (TLRs) and nucleotide-binding oligomerization
domain (NOD) proteins, cytokines such as interleukin 1b
(IL-1b) and interferon g (IFN-g), and transcription factors
such as nuclear factor kB (NF-kB) and IFN regulatory
factors (IRFs) (Oehlers et al. 2011). The mammalian fetus
is likewise protected from pathogens by a robust innate
immune system at the maternal/fetal interface, the mater-
nal decidual components of which are stromal and im-
mune cells (Abrahams 2008). Macrophages, which are of
maternal origin initially and are replaced at E9.5 by mac-
rophages that are YS-derived, also play an important role
in fetal innate immune responses (Bertrand et al. 2005).
Activation of the innate immune system results in the syn-
thesis of eicosanoids, such as leukotrienes and prostanoids,
and inflammatory cytokines, including tumor necrosis
factor (TNF), IL-1b, IL-6, IL-12, and type I and II IFNs.
Tonic innate immune signaling influences normal de-
velopmental processes. The paradigmatic example is
establishment of dorsoventral patterning of the precellu-
lar Drosophila embryo by Toll and its downstream
effector, the NF-kB homolog Dorsal (Anderson et al.
1985). Toll signaling also regulates the number of blood
cells (hemocytes) in Drosophila and the differentiation of
a particular hemocyte lineage, lamellocytes (Qiu et al.
1998). In mouse embryos, IL-1 signaling impacts hema-
topoietic stem and progenitor cells (HSPCs) in the AGM
region (Orelio et al. 2008). However, across vertebrate
species, a general role for innate immune or inflamma-
tory signaling in HSPC production in the absence of
a microbial challenge has not been proposed.
Here we show that progenitors with lymphoid poten-
tial (LPs) isolated from the major arteries (dorsal aorta,
umbilical, and vitelline) of mouse embryos have a robust
innate immune/inflammatory molecular signature. The
number of LPs in mouse and zebrafish embryos is
positively regulated by the inflammatory cytokines
IFN-g and IFN-a (IFN-u in zebrafish), with IFN-g signal-
ing also impacting the number of functional HSCs.
Furthermore, we demonstrate that inflammatory signaling
is active in human fetal HSPCs based on the expression of
known IFN target genes. Finally, we show that the primitive
myeloid population contributes to the local inflammatory
response to regulate the number of HSPCs. Together, our
data indicate that sterile tonic inflammatory signaling
regulates HSPC formation in the vertebrate embryo.
Results
Ly6a-GFP expression enriches for HSCs and cells
with lymphoid potential
A role for inflammatory signaling in definitive hematopoi-
esis was uncovered while characterizing the expression of
a transgenic HSCmarker, Ly6a-GFP. Ly6a encodes the cell
surface molecule Sca-1, which is found on all HSCs in the
FL and bone marrow (BM) but on only a subset of newly
emerging HSCs in the E11.5 AGM region (de Bruijn et al.
2002). In contrast, GFP expression from a multicopy Ly6a-
GFP transgene marks all functional AGM HSCs, as de-
termined by transplantation into adult recipient mice;
thus, unlike cell surface Sca-1, the Ly6a-GFP transgene is
a reliable marker for these cells (de Bruijn et al. 2002). To
determinewhether Ly6a-GFP expression could distinguish
HSCs from earlier and more abundant YS-derived com-
mitted EMPs, we isolated CD45+ Ly6a-GFP+ and CD45+
Ly6a-GFP cells and quantified EMPs in each population
in methylcellulose colony-forming assays conducted in
the presence of EPO, SCF, IL-6, and IL-3 (Fig. 1A).We found
that most CD45+ cells and EMPs in the YS were Ly6a-
GFP (Fig. 1B,C). In addition,most progenitors in the E11.5
FL, which at that time are primarily YS-derived EMPs
(Frame et al. 2013), were also Ly6a-GFP (Fig. 1C).
To determine whether Ly6a-GFP expressionmarks LPs,
which would include committed lymphoid progenitors
and multipotent HSPCs, we sorted cells from dissected
AGM regions and umbilical and vitelline arteries (A+U+V)
using three endothelial markers—CD31, vascular endo-
thelial cadherin (VEC), and endothelial cell (EC) adhesion
molecule (ESAM)—and further separated the cells into
intra-arterial hematopoietic cluster cells (HCCs) and
ECs using an antibody to Kit that specifically marks
the HCCs. Both HCCs (CD31+VEC+ESAM+Kit+) and
ECs (CD31+VEC+ESAM+Kit) were then segregated into
Ly6a-GFP+ and Ly6a-GFP fractions (Fig. 1D). LPs with B
lineage potential were enumerated by limiting dilution
on OP9 stromal cells, and LPs with T potential were
enumerated by limiting dilution on OP9 expressing the
Notch ligand Delta-like 1 (DL1) in the presence of Flt3
ligand (FLT3L) and IL-7 (Fig. 1F). At E10.5, only 15% of
HCCs and ECs were Ly6a-GFP+ (Fig. 1E). Notably, LPs
were present at a much higher frequency in the Ly6a-
GFP+ population of HCCs; approximately one in five
Ly6a-GFP+ HCCs had in vitro B or T lineage potential,
as compared with one in 49 Ly6a-GFP HCCs (Fig. 1G;
Supplemental Table S1). The segregation of LPs into the
Ly6a-GFP+ fraction was even more pronounced at E11.5,
with a 100-fold higher frequency in Ly6a-GFP+ versus
Ly6a-GFP HCCs (Fig. 1H; Supplemental Table S1). No
LPs were found in Ly6a-GFP+/ ECs at either E10.5 or
E11.5 (data not shown). In summary, Ly6a-GFP specifi-
cally marks HSCs (de Bruijn et al. 2002) and LPs within
intra-arterial HCCs and does not mark EMPs in the YS or
Li et al.
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FL. As Ly6a-GFP+ cells represent only 15%–20% of the
HCCs, HSCs and LPs can be greatly enriched by separat-
ing HCCs based on this marker.
Ly6a-GFP+ HCCs and ECs express genes involved
in innate immunity and inflammation
We hypothesized that signaling pathways specifically
active in Ly6a-GFP+ HCCs and ECs may regulate the
formation of HSCs and LPs from hemogenic endothe-
lium. To identify these pathways, we performed gene
expression analyses comparing Ly6a-GFP+ and Ly6a-GFP
HCCs and ECs. We sorted CD31+VEC+ESAM+Kit+/
cells from A+U+V tissue dissected from E10.5 em-
bryos, separated these populations into Ly6a-GFP+ and
Ly6a-GFP fractions, and examined gene expression of
pooled replicate samples. We found 8222 differentially
expressed genes across the four cell subtypes (P < 0.01,
one-way ANOVA). Consensus clustering of these genes,
varying the number of clusters (k) from two to 20,
identified an optimal setting of k = 8 from cumulative
distribution function (CDF) plots (Fig. 2A; Supplemental
Fig. S1). Cluster 1 (C1), which consisted of 1305 genes
with higher expression in Ly6a-GFP+ HCCs versus all
other cells, generated the largest number of highly
enriched gene ontology (GO) terms (Fig. 2B; Supplemen-
tal Fig. S2; Supplemental Tables S2, S3). By far the most
highly enriched GO term associated with C1 was ‘‘in-
nate immune response’’ (P = 10533) (Fig. 2C). Other
highly enriched GO terms in C1 were ‘‘immune re-
sponse,’’ ‘‘inflammatory response,’’ ‘‘positive regulation
of T-cell proliferation,’’ ‘‘response to bacterium,’’ ‘‘de-
fense response to virus,’’ ‘‘TLR signaling pathway,’’ ‘‘de-
fense response to protozoan,’’ and ‘‘positive regulation of
TNF production’’ (Supplemental Table S2). C1 was also
enriched for GO terms associated with lymphoid re-
sponses and differentiation (Supplemental Table S2),
consistent with the enrichment of LPs in Ly6a-GFP+ HCCs.
Figure 1. Ly6a-GFP expression marks LPs but not EMPs. (A) Scheme for isolating Ly6a-GFP+/ CD45+ cells from E11.5 embryos and
methylcellulose colony-forming assays to quantify EMPs. (B) Scatter plots of representative sort samples for colony assays. (C) Number of
EMPs per embryo equivalent (ee) of the indicated tissue. (BFU-E) Burst-forming units erythroid; (CFU-GM) colony-forming units
granulocyte/monocyte; (CFU-GEMM) CFUs granulocyte/erythrocyte/monocyte/megakaryocyte. Error bars represent mean 6 95% CI.
Data are from three replicates, using pooled embryos. P-values were calculated by t-test as described in the Materials and Methods. (D)
Representative scatter plots of cell isolation for lymphoid progenitor assays. (E) Percentage of Ly6a-GFP+ cells in the hematopoietic cluster
(HCC: CD31+VEC+ESAM+Kit+) and endothelial (EC: CD31+VEC+ESAM+Kit) populations. Data are averaged from five to six litters of
pooled embryos (mean6 SD). (F) Scheme for limiting dilution assay to enumerate progenitors with B and T potential (LPs) on OP9-GFP and
OP9-DL1 stromal cells, respectively. B cells were identified as CD19+ B220+, and Tcells were identified as CD25+ Thy1.1+. (G) Frequency of
LPs in the Ly6a-GFP+ and Ly6a-GFP fractions of HCCs from E10.5 embryos (mean 6 SD). Progenitor frequency is indicated above
columns. Data are from three experiments using pooled cells from Tg(Ly6a-GFP) embryos. Additional data, including cell numbers, are
summarized in Supplemental Table S1. (H) Frequency of LPs at E11.5, as in G (n = 4 experiments) (see also Supplemental Table S1).
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Examples of genes up-regulated in C1 include TLRs (Tlr1,
Tlr2, Tlr7, and Tlr13), histocompatibility antigens (Hmh1),
lymphocyte-associated genes (Cd69 and Fc receptor-like S
[Fcrls]), and IFN-regulated genes (Irf1, Isg20, Psmb8,RnaseI,
Tap2, and Tabpb) (Fig. 2D,E; Supplemental Table S3).
Macrophages were excluded as the major source of the
innate immune/inflammatory profile, as, by flow cytome-
try, <1% of Ly6a-GFP+ HCCs were F4/80+ (data not shown).
Therefore, we conclude that the innate immune/inflam-
matory signature is intrinsic to Ly6a-GFP+ HCCs, which
Figure 2. Ly6a-GFP+ HCCs have an innate immune/inflammatory signature. (A) Consensus clustering of microarray data from Ly6a-
GFP+ and Ly6a-GFP HCCs and ECs. Sorts were performed as in Figure 1D. Duplicate RNA samples from each population (four total;
;15,000 cells per sample) were analyzed by microarray. Each row represents one gene. Values in the key represent the frequency at
which two genes were observed to cluster together. Cluster numbers, including gene number (n) within each set, are indicated at the
right. C1 (boxed) is expanded in B. (B) Dendrogram of C1. Gene expression levels are normalized by Z-score transformation across
microarray experiments. (H) HCCs; (E) ECs. (C) Top 10 enriched GO biological process terms among C1 genes. (D) Examples of innate
immune/inflammatory genes with up-regulated expression in Ly6a-GFP+ HCCs. (E) qPCR analysis of several genes in D represented as
fold difference relative to Hprt (n = 3, mean 6 SD). Significance is by one-way ANOVA and Dunnett’s multiple comparison test with
Ly6a-GFP+ HCCs as a comparator (#). (ns) Not significant.
Li et al.
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suggests inflammatory signaling has an active role in the
specification or expansion of embryonic HSCs and LPs.
Cluster 2 (C2) consisted of genes up-regulated in both
Ly6a-GFP+ and Ly6a-GFP HCCs relative to ECs and
was enriched for the GO terms ‘‘transcription,’’
‘‘DNA-dependent,’’ and ‘‘chromatin modification’’ (Sup-
plemental Fig. S2; Supplemental Tables S2, S3). Hemato-
poietic-specific genes were not in C2, as they were more
highly expressed in Ly6a-GFP+ HCCs and segregated to
C1 (Supplemental Table S3). Cluster 3 (C3), which in-
cluded 1417 genes more highly expressed in Ly6a-GFP+
ECs versus all other populations, was significantly en-
riched for GO terms related to angiogenesis and vasculo-
genesis. Cluster 4 (C4) contained 965 genes more highly
expressed in Ly6a-GFP+ HCCs and ECs as compared with
their Ly6a-GFP counterparts and, like C1, generated GO
terms associated with innate immune/inflammatory sig-
naling (Supplemental Fig. S2; Supplemental Table S2).
However, unlike C1, C4 lackedGO terms associated with
lymphocyte differentiation and activation correlating
with the absence of LPs in the EC population. Ly6a-
GFP+ ECs and HCCs therefore share an innate immune/
inflammatory signature, suggesting that inflammatory
signaling pathways are activated in a subset of ECs that
give rise to or stimulate production of HSCs and LPs.
Type I and II IFNs regulate lymphoid progenitors
and HSCs in the fetus
Sca-1 is a well-known mediator of innate immune/
inflammatory signaling in adult mice, and its expression
is activated by proinflammatory cytokines (Luna et al.
2004; Flanagan et al. 2008; Essers et al. 2009; Purwanti
et al. 2011; Shi et al. 2013). We therefore hypothesized
that innate immune/inflammatory signaling may acti-
vate Ly6a-GFP in the embryo. To determine which
inflammatory cytokines could further elevate its expres-
sion, we cultured explanted E9.5 Tg(Ly6a-GFP) embryos
for 2 d in the presence of factors known to induce Sca-1
expression in the adult (Fig. 3). IL-1b, IL-4, and IL-6 had
very little impact on Ly6a-GFP expression in embryo
explants (Fig. 3B). TNFa caused a small but reproducible
increase in the number of Ly6a-GFP+ HCCs, while type I
and II IFN (IFN-a4 and IFN-g) dramatically increased both
Ly6a-GFP+ HCCs and ECs (Fig. 3B). The increase in Ly6a-
GFP+ cells was caused by both higher expression of Ly6a-
GFP, indicated by elevations in mean fluorescence
intensity (MFI) in HCCs and ECs (Fig. 3C), and enhanced
proliferation, seen as a higher percentage of Ki67+ cells in
both populations (Fig. 3D). We conclude that HCCs and
ECs in the embryo are wired to robustly respond directly
or indirectly to IFN stimulation.
To determine whether the response to IFN-g and IFN-
a4 in HCCs and ECs was direct, we assessed expression of
their receptors and Stat1 phosphorylation in response to
ligand. The receptor for IFN-g (IFNGR1) was present on
>95% of CD31+Kit+ YS EMPs and >95% of HCCs and ECs
in the A+U+V of E11.5 embryos, although the MFI was
eightfold lower on ECs (Fig. 4A,B). We were unable to
detect the IFN-a receptor on either HCCs or ECs for
technical reasons but found Ifnar1 mRNA in both pop-
ulations (Fig. 4C). Addition of IFN-g or IFN-a4 to disag-
Figure 3. Type I and II IFNs induce Ly6a-GFP expression in embryo explants. (A) Experimental scheme to identify inflammatory
cytokines capable of inducing Ly6a-GFP expression in 2-d embryo explant cultures. (B, top) Fluorescent images of embryo explants after
2 d of culture with the indicated cytokines (20 ng/mL). Representative histograms of GFP levels in HCCs (middle) and ECs (bottom).
Data are representative of three experiments. (C) Increase in Ly6a-GFP MFI in HCCs and ECs following 2 d of explant culture. (n = 4;
mean 6 SD; t-test). (D) Increase in the percentage of Ki67+ cells in the Ly6a-GFP+ HCC and EC populations after 2 d of explant culture
(n = 3; mean 6 SD; t-test; representative histograms are at the left).
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Figure 4. IFNg signaling regulates embryonic hematopoiesis. (A) Flow cytometry for IFNGR1 on CD31+Kit+ YS EMPs (E11.5). (FMO)
Fluorescence minus one control. (B) Flow cytometry for IFNGR1 on Ly6a-GFP+/ HCCs and ECs from the A+U+V (E11.5). (C) qPCR for
Ifnar1 mRNA in Ly6a-GFP+/ HCCs (H) and ECs (E) (E10.5) shown as fold difference/Hprt. (D) Increase in p-Stat1 in HCCs (VEC+Kit+)
but not ECs (VEC+Kit) 15 min after addition of 50 ng/mL IFN-g or IFN-a4 to disaggregated A+U+V cells (E10.5). (E) Number of EMPs
per YS in E10.5 wild-type (WT) embryos and those deficient for IFN signaling (n = 7–14 embryos; mean 6 SD; one-way ANOVA). (F)
Number of LPs per A+U+V in E10.5 wild-type embryos and those deficient in IFN-g or IFN-a signaling determined by limiting dilution
on OP9 and OP9-DL1 stromal cells. P-values for total number of LPs (B+T) calculated by one-way ANOVA and Dunnett’s multiple
comparison tests (n = 3–9 from two experiments; mean 6 SD). (G) Determination of HSC numbers by limited dilution transplantation.
Irradiated adult recipients (Ly5.1) were transplanted with the indicated fractions (1.0 or 0.3 embryo equivalents) of A+U+V cells (Ly5.2).
The contribution of donor cells (positive engraftment scored as >1%) to CD34Flt3LSK BMwas analyzed at 16 wk (n = 7–10 from eight
experiments). Number of LT-HSCs per A+U+V and significance from wild type were determined by extreme limiting dilution analysis
(Hu and Smyth 2009).
Li et al.
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gregated A+U+V cells increased p-Stat1 in the majority of
HCCs within 15 min but not in most ECs (Fig. 4D). Thus,
HCCs, but not the bulk EC population, respond rapidly
and robustly to IFNs.
More relevant is whether hematopoiesis is affected by
loss of IFN signaling. There was no decrease in YS EMP
number in E10.5 Ifng/, Ifngr1/, or Ifnar1/ embryos
(Fig. 4E), correlating with the absence of Ly6a-GFP
expression in EMPs. As >95% of EMPs are IFNGR1+
(Fig. 4A), this means that EMPs either are not exposed to
IFN-g in the YS or are unable to mount an IFN response,
or their production is unaffected by IFN-g signaling. In
contrast, there was a twofold reduction in the frequency
of LPs in the A+U+V of Ifng/, Ifngr1/, and Ifnar1/
embryos at E10.5 (Fig. 4F), indicating that IFN signaling
regulates the formation or numbers of LPs. To determine
whether IFN signaling impacts the number of functional
HSCs, we transplanted 1.0 and 0.3 embryo equivalents of
A+U+V cells from E11.5 Ifng/ and Ifngr1/ embryos
into adult mice and examined BM engraftment. There
was a trend toward reduced HSC numbers per A+U+V in
Ifng/ embryos and a significant, fourfold decrease in
Ifngr1/ embryos (Fig. 4G), indicating that IFN-g signal-
ing regulates the number of functional HSCs in the
A+U+V. Given that phenotypic long-term repopulating
HSCs are reportedly present at normal frequencies in the
adult BM of IFN-g-deficient mice (Baldridge et al. 2010),
the effects of IFN-g signaling deficiency are either tran-
sient or compensated for by other factors, modifying the
numbers of HSCs that emerge at E11.5 in the A+U+V but
not HSC maintenance.
A role for IFN signaling is conserved in zebrafish
Zebrafish possess two genes homologous to mammalian
Ifng (ifng1-1 and ifng1-2) and three genes that encode the
Ifng receptor (crfb6, crfb13, and crfb17). Morpholinos
(MOs) targeting both ifng1-1 and ifng1-2 (combination
referred to as Ifng MO) decreased runx1 expression in the
AGM region at 33 h post-fertilization (hpf), as did com-
bined knockdown of crfb6, crfb13, and crfb17 (referred to
as Ifngr MO) (Fig. 5A,B). Elevation of IFN-g levels by
injection of ifng1-1mRNA into embryos increased runx1
expression in the AGM (Fig. 5A,B), indicating that IFN-g
signaling induces HSPC formation in vivo. The impact of
MO-mediated Ifng/Ifngr loss was due to a decrease in
total cell number rather than runx1 expression per cell, as
the number of flk1:dsRed+cmyb:gfp+ AGM HSPCs (flk1:
dsRed marks ECs and HSCs, and cmyb:gfp marks HSCs
and myeloid progenitors) (Bertrand et al. 2010) was also
reduced (Supplemental Fig. S3A,B). MOs targeting Ifng
and Ifngr similarly decreased the number of cd41:gfp+
HSCs in the caudal hematopoietic territory (CHT), a site
of colonization and expansion of AGM-derived cells,
between 36 and 72 hpf (Fig. 5C,D). Expression of rag1 in
the thymus and the number of rag2:dsRed+ thymocytes
were subsequently diminished (Fig. 5E–G). In contrast,
the percentage of lmo2:GFP+gata1:dsRed+ EMPs was not
impacted (Supplemental Fig. S3C). The efficiency of the
Ifng knockdown was confirmed by altered expression of
several known IFN-g target genes (Supplemental Fig.
S3D). Vascular development, maturation, and circulation
in zebrafish morphants (Supplemental Fig. S3E,F) as well
as vascular morphology in IFN-g signaling-deficient mu-
rine embryos (Supplemental Fig. S3G) appeared normal,
indicating that reductions in HSPC number were not
secondary to gross vascular defects.
IFN-a has no zebrafish equivalent, but there are four
type I IFN genes in zebrafish not found in mammals,
referred to as ifnphi 1–4 (Levraud et al. 2007). The dimeric
receptor for each of the IFN-u isoforms uses one specific
(crfb1 or crfb2) and one common (crfb5) chain. MO
knockdown of Ifnu1+4, Ifnu2+3, or the common receptor
chain crfb5 decreased runx1 and rag1 expression in the
AGM and thymus, respectively (Fig. 5H–K). Knockdown
of IFN-us and crfb5 decreased the number of cd41:gfp+
cells in the CHT (Fig. 5L) alone and in combination with
Ifng-MO (Fig. 5M). Thus, as in mice, multiple IFNs
regulate embryonic HSPC production in zebrafish.
IRF2 occupies enhancers in human CD34+ FL cells
To provide further evidence that sterile IFN signaling was
active in embryonic HSPCs, we examined the expression
of IFN target genes in mouse and human embryos. IFN
target genes were identified by chromatin occupancy of
the transcription factor IRF2 in human CD34+ FL HSPCs;
IRF2 was selected out of the nine IRF genes in mice, as it
is the only IRF known to function in adult HSCs, where it
promotes quiescence and engraftment by dampening IFN
signaling (Sato et al. 2009). We identified 2833 IRF2-
bound peaks in hCD34+ FL cells (Fig. 6A). To systemat-
ically identify IRF2 targets, we used the genomics regions
enrichment of annotation tool (GREAT). Although asso-
ciating transcription factor chromatin immunoprecipita-
tion (ChIP) combined with sequencing (ChIP-seq) peaks
with their target genes is computationally challenging
and all bioinformatic tools have limitations, GREAT is
superior to themore commonly used nearest-gene strategy
(McLean et al. 2010). GREAT revealed multiple signifi-
cantly enriched (false discovery rate [FDR]Q-value < 0.05)
GO terms and pathways, including IFN signaling (Fig. 6B;
Supplemental Table S4). Genes within several of the
enriched functional categories weremore highly expressed
in hCD34+ FL HSPCs compared with all genes as a whole
(Fig. 6C,D) and relative to the core embryonic stem cell
genes OCT4 and NANOG (Supplemental Fig. S4A), pro-
viding further evidence for their correct association as
IRF2 target genes. Finally, to demonstrate relevance
across systems, we showed that representative IRF2-
occupied genes are expressed in mouse FL HSCs
(Supplemental Fig. S4B).
We compared the expression of IRF2-occupied genes in
hCD34+ FL HSPCs with that of genes up-regulated in
Ly6a-GFP+ HCCs (C1) and found significant overlap in the
expression of orthologous IFN signaling-related genes
(Fig. 6A; Supplemental Table S4). Expression of several
of these genes in Ly6a-GFP+ HCCs was confirmed by
quantitative PCR (qPCR) (Supplemental Fig. S4C). ChIP-
seq signal plots illustrate IRF2 occupancy of representative
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Figure 5. IFN signaling regulates hematopoiesis in zebrafish embryos. (A) Whole-mount in situ hybridization (WISH) for runx1 in the
AGM region of representative embryos injected with MOs targeting Ifng (ifng1.1 plus ifng1.2) or the IFN-g receptors (crfb6, crfb13, and
crfb17) (Ifngr MO) or with mRNA for ifng1-1 compared with sibling controls at 33 hpf (n $ 100 embryos per condition, from four
experiments). (B) Bar graph showing qualitative phenotypic distribution as percent of embryos from A scored with low, medium, or high
runx1 expression in the AGM. (C) Representative effects of Ifng and Ifngr knockdown on cd41:gfp+ HSPCs in the CHT at 48 hpf. Boxed
areas in the top panels are magnified in the panels below. (D) Absolute counts of cd41:gfp+ cells in the CHTwere determined at fixed
time intervals (n $ 17 embryos per condition). P-value, determined for each time point relative to control (#), was #0.0001 at all time
windows. (E) WISH for rag1 expression in the thymi of representative embryos at 5 dpf following Ifng and Ifngr knockdown (n $ 7
embryos per condition). (F) Qualitative phenotypic distribution as percentage of embryos scored with low, medium, or high rag1
expression. (G) Percentage of rag2:dsRed+ cells in total 5-dpf fish embryos quantified by flow cytometry (ANOVA, n $ 4 replicates of
five pooled embryos). (H) WISH for runx1 in the AGM of representative embryos (n $ 23 embryos per condition) injected with paired
MOs targeting IFN-us. (I) Phenotype distribution of embryos from H, scored as in B. (J) WISH for rag1 in the thymi of representative
embryos (n $ 23 embryos per condition) injected with paired MOs targeting IFN-us. (K) Phenotype distribution of embryos from J,
scored as in F. (L) cd41:gfp+ cells in the CHT following MO knockdown of IFN-us and crfb5 (n $ 19 embryos per condition). Error bars
indicate SD. (ns) Not significant. (M) cd41:gfp+ cells in the CHT at 38 hpf following MO knockdown of Ifng and crfb5 alone or in
combination (n = 8–20 embryos per condition).
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Figure 6. IRF2 target genes in human CD34+ FL HSPCs overlap with IFN pathway genes and C1 genes. (A) Venn diagram of IFN signaling
genes expressed in hCD34+ FL HSPCs, C1 genes (expressed in Ly6a-GFP+ HCCs), and IRF2-bound genes in hCD34+ FL HSPCs. P-values for
overlap between all three sets were computed using a hypergeometric test. P-values for overlap of IRF2-bound and expressed genes were
computed using GREAT. (B) Enriched GO biological process terms for IRF2-bound genes determined by GREAT. (C) Expression levels of
IRF2-bound targets relative to all genes in hCD34+ FL HSPCs enriched for GO terms. P-values (in parentheses) as computed by t-test. Gene
expression was analyzed from previously published Affymetrix microarray data (Xu et al. 2012). Only genes annotated with GO terms that
had significantly different expression compared with the genome background are shown. (D) Expression levels of all genes and IRF2-bound
genes in hCD34+ FL HSPCs enriched for representative pathway terms, as in C. (E) ChIP-seq signals for representative IFN pathway genes
bound by IRF2. (F) Phenotype distribution of runx1 expression byWISH (AGM region) for irf2amorphants generated with two independent
MOs compared with sibling controls (n $ 40 embryos per condition). (G) Absolute number of cd41:gfp+ HSPCs in the CHT of irf2a
morphants at 38 hpf (n = 17; mean 6 SD; t-test). (H) Percent of rag2:dsRed+ cells in whole embryos at 5 dpf by flow cytometry in irf2a
morphants (n = 7; mean 6 SD; t-test). (I) qPCR for IRF2 target genes in irf2a morphants (n = 2, from four replicates; mean 6 SD; t-test).
genes that were expressed in both human FL CD34+ cells
and mouse Ly6a-GFP+ HCCs (Fig. 6E). We conclude that
IFN signaling, as evidenced by expression of IRF2-bound
genes, is occurring in human HSPCs, mouse FL HSCs, and
Ly6a-GFP+ HCCs.
Since IRF2 attenuates IFN signaling in adult HSCs, we
asked whether IRF2 negatively regulates HSPC formation
in the embryo. MO knockdown of irf2a in zebrafish
embryos increased runx1 expression in the AGM (Fig.
6F; Supplemental Fig. S4E) and cd41:gfp+ cells in the CHT
(Fig. 6G). Thymic rag1 expression (data not shown) and
the number of rag2:dsRed+ cells (Fig. 6H) also increased in
irf2a morphants, as did IRF2 target gene expression (Fig.
6I), including components of the IFN signaling cascade.
Thus, IRF2 negatively regulates HSPC formation or
numbers in zebrafish embryos, likely by dampening IFN
signaling. These data confirm that IFN signaling is
normally active during the window of HSPC production
in the AGM.
Multiple cells in the embryo express inflammatory
cytokines
As the number of HSPCs in both mouse and zebrafish
embryos was reduced but not eliminated by loss of IFN
signaling, we determined whether additional proinflam-
matory cytokines contribute to HSPC production alone
or in combination with IFN. IL-1b was previously shown
to modulate HSC formation in the murine AGM region
(Orelio et al. 2008), and TNF caused a small increase in
Ly6a-GFP expression in E9.5 embryo explants (Fig. 3B). In
zebrafish embryos, both tnfa and il1b morphants had
lower runx1 expression in the AGM (Fig. 7A) and fewer
cd41-gfp+ cells in the CHT (Fig. 7B,D). Combinatorial MO
knockdown of ifng and tnfa caused a greater decrease in
runx1 expression than knockdown of either gene alone at
33 hpf (Fig. 7C) and sustained the effect of Ifng-MO at 72
hpf (Fig. 7D). Thus, multiple inflammatory cytokines can
cooperate in the formation and expansion of embryonic
HSPCs in the absence of pathological stimulation.
We next sought to identify cellular sources of inflam-
matory cytokines. To determine whether the source of
IFN-g in mice was embryonic or maternal, we mea-
sured the number of LPs in Ifng+/ fetuses from wild-type,
Ifng+/, or Ifng/ dams. The number of LPs was not
influenced by the genotype of the dam (Fig. 7E), indicating
that the primary source of IFN-g is embryonic. However,
Ifng mRNA was undetectable in cells from whole A+U+V
tissue (data not shown) or isolated A+U+V subsets (ECs,
macrophages [F4/80+], granulocytes [Gr1+], and Ly6a-GFP+/
HCCs) but was present in macrophages from adult mouse
spleens (F4/80+Mac1+Ter119Gr1) (Fig. 7F). Similarly,
FACS-sorted ECs (flk1:dsRed+cmyb:GFP) and macro-
phages (flk1:dsRedmpeg:GFP+) from zebrafish embryos
contained virtually undetectable levels of ifng1-1 or
ifng1-2 mRNAs. In contrast, HSPCs (flk1:dsRed+cmyb:
GFP+) expressed ifng1-2 (Fig. 7G) and possessed detectable
levels of ifng1-1. ifng1-1 mRNA, which is deposited
maternally and persists throughout zebrafish develop-
ment (Sieger et al. 2009), was also present in disaggregated
embryos from which ECs (including cmyb+ HSPCs) and
macrophages were depleted (flk1mpeg) (Fig. 7G). In
mouse embryos, placental embryonic trophoblasts se-
crete IFN-g beginning at E10 (Platt and Hunt 1998). Thus,
the relevant cellular sources of IFN-g in zebrafish and
mouse embryos may not be located in the immediate
vicinity of the emerging HSPCs but rather originate from
more distant sites. On the other hand, Ifna and ifnphi1
mRNAs were found in ECs in mouse and zebrafish
embryos, respectively (Fig. 7F,G), and may function as
a local source of IFN signaling during HSPC production
from hemogenic endothelium; indeed, expression analy-
sis of IRF2 morphant embryos indicated that ifnphi1+3
were significantly increased in the presence of elevated
IFN-g signaling (Supplemental Fig. S4F).
Although macrophages in zebrafish and mouse em-
bryos express little or no IFN-g, they contained high
levels of TNF and IL1-b mRNAs (Fig. 7F,G), consistent
with their well-characterized responses to IFN-mediated
inflammatory stimulation. Zebrafish macrophages also
expressed high levels of mRNA encoding receptors for
IFNs (crfb13, crfb17, and crfb5) and transcriptional me-
diators of IFN signaling (stat1a, stat2, irf1b, irf2a, and
irf8) (Fig. 7H,I), suggesting that they can be activated
by IFN signaling and relay that signal to HSPCs. To
determine whether primitive macrophages influenced
HSPC formation, we depleted macrophages using MOs
targeting irf8 or all primitive myeloid cells with com-
bined MOs for spi1b and its paralog, spi1a. MOs against
irf8 reduced the number of csf1ra+ macrophages (Fig. 7J),
as expected, as well as expression of runx1 in the AGM
(Fig. 7K) and the number of cd41:gfp+ cells in the CHT
(Fig. 7L). Combinatorial knockdown of spi1b + spi1a,
which decreased the production of both irf8+ macro-
phages and mpo+ granulocytes, dramatically reduced
runx1 expression in the AGM (Fig. 7M–O; Supplemental
Fig. S5A). Furthermore, spi1b/spi1a loss caused sustained
reductions in cd41:gfp+ HSPCs in the CHT at 72 hpf (cf.
Figs. 7L and 5D,L), implying that primitive myeloid cells
serve to amplify proinflammatory inductive signals reg-
ulating HSPC numbers. In the AGM region of E10.5
mouse embryos, macrophages are located in the vicinity
of intra-arterial HCCs (Supplemental Fig. S5B), including
some observed with projections inserted between Ly6a-
GFP+ ECs (Supplemental Fig. S5C,D). Therefore, prim-
itive myeloid lineage cells may act as a local source of
inflammatory signals to aid the production of vertebrate
HSCs and LPs.
Discussion
Multiple signaling pathways work sequentially and in
concert to promote hematopoietic cell formation in the
embryo. Here we report that innate immune/inflamma-
tory signaling is one of those pathways. We show that
mouse embryos are capable of robustly responding to the
inflammatory molecules IFN-a4 and IFN-g. The numbers
of LPs in mouse embryos deficient in IFN-g or the IFN-g
and IFN-a receptors are significantly reduced, as are
transplantable HSCs in embryos lacking the IFN-g
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Figure 7. Multiple inflammatory cytokines and primitive myeloid cells promote HSPC formation. (A) Phenotype distribution of runx1
expression by WISH (AGM region) for tnfa or il1bmorphants compared with sibling controls (n$ 77 embryos per condition). (B) Absolute
number of cd41:gfp+ HSPCs in the CHTof il1bmorphants (n $ 17; mean 6 SD; t-test). (C) Phenotype distribution of runx1 expression by
WISH (AGM) for lnfg knockdown alone and in combination with tnfaMOs (n $ 54 embryos per condition). (D) Absolute counts of cd41:
gfp+ cells in the CHT determined at fixed times intervals in embryos (n$ 18 embryos per condition) with lnfg MO6 tnfaMO. P-value, as
in Figure 5D, was #0.0001 at each time point (one-way ANOVA; [ns] not significant). (E) Number of LPs per A+U+V in E10.5 Ifng+/
mouse embryos from wild-type (+/+), Ifng+/, and Ifng/ dams (n = 3; mean6 SD; t-test). (F) qPCR for proinflammatory cytokine mRNAs
in E10.5 mouse ECs (CD31+VEC+Kit), macrophages (F4/80+), granulocytes (Gr1+), and Ly6a-GFP+/ HCCs, normalized to Hprt (n = 3;
mean 6 SD). mRNA levels in professional inflammatory cells (F4/80+ Mac1+ Ter119 Gr1 macrophages) are shown for comparison. (G)
qPCR for proinflammatory cytokine mRNAs from sorted zebrafish embryo fractions: EC (flk1+cmyb), macrophage (flk1mpeg+), HCC
(flk1+cmyb+), and nonhematovascular (flk1mpeg) (normalized to 18S; n = 2 replicates in two experiments; mean6 SD; t-test). (H) qPCR
for IFN pathway regulatory targets and transcription factors from sorted zebrafish embryo fractions, as in G. (I) qPCR for IFN-g and IFN-u
receptor mRNAs from sorted zebrafish embryo fractions, as above. (J) Phenotype distribution of csf1ra expression by WISH in irf8
morphants (n $ 31 embryos per condition). (K) Phenotype distribution of runx1 expression by WISH (AGM) in irf8 morphants (n $ 28
embryos per condition). (L) Absolute counts of cd41:gfp+ cells in the CHT, as in D, following irf8 knockdown or combinatorial reductions
of spi1a and spi1b (n$ 29 embryos per condition; one-way ANOVA). (M) Phenotype distribution of irf8 expression byWISH followingMO
knockdown of spi1a and spi1b alone and in combination (n$ 28 embryos per condition). (N) Phenotype distribution ofmpo expression by
WISH following MO knockdown, as inM (n$ 29 embryos per condition). (O) Phenotype distribution of runx1 expression byWISH (AGM)
following MO knockdown (n $ 40 embryos per condition).
receptor. A role for IFN signaling in HSPC and LP
formation and/or number is evolutionarily conserved,
as MO knockdown of IFN-g or its receptors and IFN-u
or its receptors decreased HSPCs and thymocytes in
zebrafish embryos, while, conversely, knockdown of
irf2a, a negative regulator of IFN-a signaling, had the
opposite effect. In contrast, EMP number in mouse or
zebrafish embryos was not affected by loss of IFN
signaling. The selective response of LPs and HSCs to loss
of IFN signaling correlated with a robust innate immune/
inflammatory expression signature in these cells. IRF2
occupancy of enhancers in human CD34+ FL HSPCs and
the expression of IRF2 target genes in those cells as well
as in HCCs in mice provided further evidence for active
IFN signaling in HSPCs of the conceptus. We conclude
that tonic inflammatory signaling has a conserved de-
velopmental function to enhance formation of HSPCs in
the embryo.
There appear to be multiple cellular sources of in-
flammatory cytokines in the developing embryo. For
example, monocytes/macrophages, which are widely
distributed in the embryo, including in the vicinity of
blood-producing arteries, and in some cases intimately
associated with Ly6a-GFP+ endothelium, express TNF
and IL-1b in both mouse and fish embryos. Embryonic
macrophages are competent innate immune cells: They
express TLRs and can be stimulated to produce multiple
cytokines and chemokines (Balounova et al. 2014). In fact,
inflammatory responses in the absence of overt infec-
tions are actively restrained in fetal macrophages. Mac-
rophages are the precursors for microglia cells in the
brain, and mutations in a noncanonical NOD-like recep-
tor, nlrc3-like, in the zebrafish embryo resulted in an
unchecked inflammatory response in primitive macro-
phages that prevented them from differentiating into
microglia (Shiau et al. 2013). Here, reduction in the
number of macrophages and other primitive myeloid
lineage cells through MO knockdown of their essential
regulators (irf8 and spi1b/spi1a) lowered HSPC produc-
tion and, in the case of combined spi1b/spi1a MOs,
reduced HSPCs even more dramatically than the loss of
individual cytokines. Thus, there is likely to be redun-
dancy in and cooperativity between different classes of
cytokines, which may explain why the removal of in-
dividual factors, in the absence of infection, had a rela-
tively modest effect and did not completely inhibit HSPC
formation. Furthermore, our data suggest that robust
production of the primitive myeloid populationmay have
developed or expanded in part to aid HSPC production
rather than simply prepare the early embryo to fight
potential infections.
Although it is plausible that exposure of nonmamma-
lian embryos to environmental pathogens could play
a role in stimulating innate immune/inflammatory sig-
naling to drive a developmental process, we do not en-
vision that the mammalian fetus would rely on mater-
nal transmission of pathogens to convey such a signal.
Rather, we hypothesize that normal developmental
events would activate innate immune/inflammatory sig-
naling. These events could include apoptosis or hypoxia,
both of which are extensive in the embryo. The expres-
sion of endogenous retroviruses in the fetal extraembry-
onic tissues of placental mammals could also trigger
innate immune/inflammatory signaling. An interesting
question is why the embryo evolved to use innate
immune/inflammatory signaling pathways to promote
HSPC formation. One possibility is that tonic innate
immune/inflammatory signaling in the fetus may func-
tion to prime genes in the emergent cells of the adaptive
immune system, enabling the cells to mount an effective
response to pathogenic challenge should or when the
fetus or adult encounter one. A more fundamental, de-
velopmental role for inflammatory signaling might be to
promote the vascular remodeling associated with HCC
formation, the migration of HSPCs to the FL or CHT,
extravasation into these sites of secondary colonization,
and/or HSPC expansion, all of which are processes
associated with classical inflammatory responses.
On a more practical note, attempts to generate HSCs
frommouse or human embryonic stem cells have thus far
failed, and perhaps careful modulation of inflammatory
signaling could improve current in vitro differentiation
protocols. We note that prostaglandin E2, which is a small
inflammatory signaling molecule, increased HSPC for-
mation in zebrafish embryos and engraftment of adult
mouse and human HSCs (North et al. 2007; Hoggatt et al.
2009), consistent with this notion. Likewise, flow-medi-
ated production of nitric oxide, also known to be secreted
from inflammatory cells, has been shown to robustly
induce HSPC production in vivo and in vitro (Adamo
et al. 2009; North et al. 2009). Additional expression
profiling of the primitive myeloid populations active in
the AGM throughout the course of HSC and LP specifi-
cation, production, and budding will further clarify the
timing and complexities of inflammatory modulation in
these processes; however, it is clear that inflammatory
signaling has a previously unappreciated yet fundamental
role in embryonic HSPC production.
Materials and methods
Mouse lines and embryo production
Tg(Ly6a-GFP) mice [B6.Cg-Tg(Ly6a-GFP)G5Dzk/J] were de-
scribed previously (Ma et al. 2002). Ifnar1Tm1Agt mice were
provided by Dr. Carolina Lopez. C57BL/6J, C57BL/6 3 129S1/
SVImJ F1, Ifng/ (B6.129S7-Ifngtm1Ts/J), and Ifngr1/
(B6.129S7-Ifngr1tm1Agt/J) mice were from Jackson Laboratory,
and B6.SJL-Ptprca Pepcb/BoyJ (CD45.1) mice from the National
Cancer Institute. Tg(Ly6a-GFP) conceptuses were generated by
crossing C57BL/63 129S1/SVImJ F1 females with Tg(Ly6a-GFP)
males.
Zebrafish husbandry
Zebrafish were maintained according to Institutional Ani-
mal Care and Use Committee (IACUC)-approved protocols.
Tg[-6.0itga2b(CD41):eGFP] (Lin et al. 2005), Tg[kdrl(flk1):dsRed2]
(Kikuchi et al. 2011), Tg(cmyb:eGFP) (North et al. 2007), Tg(rag2:
dsRed) (Ma et al. 2012), Tg(mpeg1:GFP) (Ellett et al. 2011), and
Tg(kdrl:GFP) (Jin et al. 2005) lines were described previously.
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MO and RNA injection
Optimized doses of MOs (50 mM to 0.25 mM; GeneTools)
(Supplemental Table S5) were injected into one-cell stage em-
bryos as described previously (North et al. 2009). ifng1-1mRNA
was synthesized using the manufacturer’s directions for Ambion
mMessage mMachine, and 400 pg was injected into one-cell
stage embryos.
Whole-mount in situ hybridization (WISH)
WISH was performed on 4% PFA-fixed embryos at the time
points indicated using previously published probes (Li et al. 2011;
Carroll et al. 2014) and established methods (http://zfin.org/
ZFIN/Methods/ThisseProtocol.html). Qualitative phenotypes
(two or more replicate clutches; n = 15–100 embryos per
condition) were scored using a dissecting microscope (Zeiss) as
high/medium/low expression compared with sibling controls.
Progenitor assays
Embryonic cells were prepared for flow cytometry and methyl-
cellulose assays as described previously (North et al. 2002; Chen
et al. 2009). OP9 and OP9-DL1 stromal (in aMEM containing
20% FBS and antibiotics) were plated into 96-well plates at
a concentration of 5500 cells per well 1 d before dilutions of
embryonic cells were added. Recombinant Flt3L and IL-7 were
added (5 ng/mL and 10 ng/mL for OP9, respectively, or 5 ng/mL
and 1 ng/mL for OP9-DL1) (Peprotech). Cells were analyzed
by flow cytometry 12 d later. B cells were identified as CD19+
B220+, and T cells were identified as CD25+ Thy1.1+. The pro-
genitor frequency was calculated using L-Calc software (StemCell
Technologies).
Cell sorting and flow cytometry
For mice, the following antibodies were used: Alexa Fluor 647
anti-CD144 (eBioBV13), PE anti-CD45 (30-F11), PE-Cy7 anti-
CD31 (390), APC- eFluor 780 anti-c-kit (2B8), PE-anti-ESAM
(1G8/ESAM), APC anti-CD19 (1D3), PE-Cy7 anti-B220 (RA3-
6B2), PE-Cy anti-Thy1.2 (53-2.1), APC-C7 anti-CD25 (PC61),
PerCP-Cy5.5 anti-Gr-1 (RB6-8C5), PE anti-CD3e (145-2C11),
APC-Cy7 anti-Mac-1 (M1/70), FITC anti-CD45.2 (104), PE-Cy7
anti-CD45.1 (A20), PerCP-Cy5.5 anti-Sca1 (D7), eFluor 450
lineage-specific cocktail [(anti-TER119 (TER119), anti-Gr-1
(RB6-8C5), anti-B220 (RA3-6B2), anti- CD3 (17A2), and anti-
Mac-1 (M1/70)], APC anti-CD34 (MEC14.7), PE anti-Flt3
(A2F10), PE anti-IFNgr1 (2E2, Abcam), APC anti-CD48
(HM48-1), and PE-Cy7 anti-CD150 (TC15-12F12.2). DAPI was
used to exclude dead cells. Cells were sorted on a BD FACS-
vantage at low speed and low pressure (North et al. 2002) and
analyzed on a BD LSR II flow cytometer; data were analyzed
with FlowJo (Tree Star).
For zebrafish, transgenic embryos (five per sample with four or
more replicates) were incubated in 0.5 mg/mL Liberase (Roche)
solution with gentle agitation for 90 min at 37°C and then
dissociated, filtered, and washed with PBS. Dead cells were
excluded by 5 nM SYTOX red (Life Technologies) prior to analysis
using a BD FACS Canto II or Beckman Coulter Gallios. Cell
sorting was performed using a Beckman Coulter MoFlo XCP.
Microarray
Thirty-thousand Ly6a-GFP+ HCCs (CD31+ VEC+ ESAM+ Kit+),
130,000 Ly6a-GFP HCCs, 70,000 Ly6a-GFP+ ECs (CD31+ VEC+
ESAM+ Kit), and 300,000 Ly6a-GFP ECs were sorted from 100
E10.5 Tg(Ly6a-GFP) embryos into TRIzol-LS (Invitrogen). RNA
was isolated using Qiagen RNeasy minikit (Qiagen), split into
two fractions, amplified by the Ovation RNA-seq system version
2 (NuGEN), and hybridized to an Agilent 4x44k Whole-Mouse
Genome version 2 oligonucleotide microarray. The Gene Ex-
pression Omnibus accession number is GSE55493.
Embryo explant culture
Heads and tails were removed from E9.5 Tg(Ly6a-GFP) embryos,
and the body was cultured in DMEM + 1% FBS in a 24-well plate
at 37°C (Rojas et al. 2005). Recombinant mouse cytokines (20
ng/mL) were added to the culture. Embryos with beating hearts
at 48 h were harvested for analysis by fluorescent microscopy
and flow cytometry.
Transplant analyses
B6.SJL-PtprcaPepcb/BoyJ (CD45.1) mice were subjected to a split
dose of 900 cGy 3 h apart. Each recipient received 1.0 or 0.3 embryo
equivalents of E11.5 A+U+Vwith 23 105 carrier spleen cells by tail
vein injection. Donor engraftment was assessed (CD45.2) in
peripheral blood at weeks 3, 7, 12, and 16 and in BM at week 16
post-transplantation. HSC frequencies were determined by ex-
treme limiting dilution analysis (ELDA) (Hu and Smyth 2009).
Whole-mount fluorescence microscopy
For mice, whole-mount confocal microscopy was performed
as described (Yokomizo et al. 2012). Embryos were stained with
rat anti-CD31 (MEC13.3, BD Biosciences), rabbit anti-Runx
(EPR3099, Abcam), chicken anti-GFP (Invitrogen Molecular
Probes), and rat anti-F4/80 (CI: A3-1, Abcam) primary antibodies
and goat anti-rat Alexa Fluor 555 (Abcam), goat anti-rabbit Alexa
Fluor 488, goat anti-chicken Alexa Fluor 647 (Jackson Immuno-
research), and goat anti-rat Alexa Fluor 647 (Invitrogen Molecu-
lar Probes) secondary antibodies. Specimens were analyzed using
a Zeiss LSM 710 confocal microscope with 253 objectives using
multitrack sequential mode. The pinhole was set at 1 airy unit;
for three-dimensional (3D) reconstructions, steps were 5 mm per
z-section.
For zebrafish, fluorescent reporter embryos were treated as
indicated in the text and live-imaged under tricaine anesthesia as
previously described (North et al. 2007) using a Zeiss SteREO
Discovery V8 microscope.
Quantitative real-time PCR analysis
For mice, RNA was extracted using Qiagen RNeasy minikit
(Qiagen) and reverse-transcribed into cDNAwith High-Capacity
cDNA reverse transcription kit (Applied Biosystems). qPCR was
performed using Power SYBR Green PCR kit (Applied Biosys-
tems) and run on a 7900HT Fast Real-Time PCR system (Applied
Biosystems). Human and mouse qPCR primers are listed in
Supplemental Tables S6 and S7.
For zebrafish, RNAwas extracted using RNAqueous microkit
(Life Technologies). cDNA was synthetized and amplified using
Ovation Pico WTA system version 2 (Nugen) prior to qPCR.
qPCR was performed on cDNA isolated from pooled embryos
using the Bio-Rad CFX384 detection system. Zebrafish primer
sequences are listed in Supplemental Table S8.
ChIP and ChIP-seq
ChIP-seq analysis of IRF2 was performed using chromatin pre-
pared from primary human FL CD34+ HSPCs, as previously
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described (Xu et al. 2012). Chromatin was immunoprecipitated
using anti-IRF2 antibodies (ABE115, Millipore; ab55331, Abcam)
or normal rabbit IgG (sc-2027, Santa Cruz Biotechnology). ChIP
DNA was isolated and processed for library generation followed
by sequencing using the Illumina HiSeq2500 platform. Raw
ChIP-seq data were processed using the Illumina software
pipeline and aligned to reference human genome (USCS, hg19).
Intracellular and phospho-flow cytometry
Cells from dissociated E10.5 AGM regions were incubated for
1.5 h at 37°C at a concentration of 23 106 per milliliter in IMDM
prior to cytokine stimulation. Recombinant mouse IFN-g or
IFN-a4 (50 ng/mL) was added, and cells were incubated for
15 min at 37°C. Cells were fixed with 1.5% paraformaldehyde
for 10 min at room temperature and permeabilized with 90%
methanol for 20 min at 4°C. Cells were then stained with PE
anti-phospho stat1 (Y701) (4a, BD Biosciences), APC- eFluor 780
anti-c-kit, and APC anti-CD144 (VEC). To stain Ki67, cells were
collected by FACS after E9.5 embryo explant culture with or
without 20 ng/mL recombinant mouse IFN-g for 2 d, fixed and
permeabilized with Cytofix/Cytoperm kit (BD Biosciences), and
stained with PE anti-Ki67 (SolA15, eBioscience).
Microarray data analysis
Raw Agilent microarray hybridization signals were normalized
using quantile normalization in the R package limma (Smyth
2004). Differentially expressed genes were detected using one-
way ANOVA. At the P-value cutoff of 0.01, we identified
8222 differentially expressed genes across the four cell types.
We performed consensus clustering using the R package
ConsensusClusterPlus (Wilkerson and Hayes 2010) that im-
plements the Consensus Clustering algorithm by Monti et al.
(2003). Level 3 GO annotation terms were used. Statistical
significance of term enrichment was computed using hyper-
geometric distribution. P-values were corrected for multiple
testing using the method of Benjamini and Hochberg (1995).
ChIP-seq data analysis
Model-based analysis for ChIP-seq (MACS) (Zhang et al. 2008),
with its default parameter settings, was used to identify IRF2-
binding peaks.
GREAT analysis
GREAT (McLean et al. 2010) was used to identify functional
categories enriched among genes bound by IRF2. GREAT de-
termines enrichment by associating the ChIP-seq peak regions
with nearby genes and uses the gene annotations to compute
enrichment. Association with gene annotation is a two-step
process. First, every gene is assigned a regulatory domain; the
default parameters (basal plus extension) were used to assign the
regulatory domain for each gene. Next, each IRF2 peak was
associated with all genes whose regulatory domains it over-
lapped. Enrichment P-values were computed using hypergeo-
metric test. A FDR of 0.05 was used as the enrichment cutoff.
Statistics analysis
The significance of multivariable comparisons throughout the
study was determined by one-way ANOVA and Dunnett’s
multiple comparison test. Pairwise variation from control was
determined by unpaired two-tailed Students t-test.
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